CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion The REVASC Trial 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

Expert Opinion17 January 2021

JOURNAL:Eur Heart J. Article Link

The Year in Cardiovascular Medicine 2020: Coronary Intervention

M Nicholls. Keywords: coronary intervention; PCI strategy

Full Text PDF